Polpharma Pharmaceutical Works - API Manufacturer

drukuj

Current API product portfolio   

Diclofenac sodium

Specification:
  • Ph.Eur.
chemical name: sodium 2-[(2,6-dichlorophenyl)amino]phenyl]acetate
molecular formula: C14H10Cl2NNaO2
structural formula: structural formula
molecular weight: 318.1
CAS Registery number: 15307-79-6

General information:

White or slightly yellowish crystalline powder, slightly hygroscopic, sparingly soluble in water, freely soluble in methanol, soluble in alcohol, slightly soluble in acetone. It melts at 2800 with decomposition.

TESTS REQUIERMENTS METHODS
Identification:

A. IR spectrum


B. TLC




C. chemical

D. chemical


comparison with reference substance spectrum

the principal spot in the chromatogram is similar in position and size to the principal spot in the chromatogram obtained with reference solution

conforms

conforms
Ph. Eur.
Appearance of 5% solution in methanol the solution is clear, the absorbance measured at 440 nm is not greater than 0.05 Ph. Eur.
Related substances (HPLC):

- single impurity

- total impuritie


not more then 0.2%

not more then 0.5%
Ph. Eur.
Heavy metals not more than 10 ppm Ph. Eur.
Loss on drying not more than 0.5% Ph. Eur.
Content of diclofenac sodium calculated on driad substance 99.0% to 101.0% Ph. Eur.
Residual solvents:

- methanol

- 2-propanol

- chlorobenzene

- n-butanol


not more than 1500 ppm

not more than 2500 ppm

not more than 180 ppm

not more than 2500 ppm
POLPHARMA
« back to API list

Latest news

CEP for Baclofen available

Monday, 02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of...

Polpharma – the most innovative company in Poland

Friday, 20-05-2011
Polpharma ranked first as the most innovative company in Poland, in a research study run by the Institute...

Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex

Friday, 08-10-2010
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex for the...

Co-operation between Polpharma and RPG Life Sciences

Tuesday, 05-10-2010
RPGLS and Polpharma announced their co-operation in the development and manufacture of Active...
© POLPHARMA S.A. All rights reserved.
Realizacja: Ideo